Skip to main content
. 2013 Aug 6;173(3):430–437. doi: 10.1111/cei.12140

Figure 1.

Figure 1

Effect of bacille Calmette–Guérin (BCG)/DNAhsp65 prime-boost in streptozotocin (STZ)-induced diabetes. (a) Weight variation and (b) blood glucose concentration were measured weekly in C57BL/c mice. The first measurement was performed before STZ inoculation and the other three were performed 7, 13 and 21 days after the last STZ dose. BCG and pVAXhsp65 were administered before diabetes induction. The histopathological analysis of the pancreatic islets (c) was performed 21 days after the last STZ administration in pancreas sections stained with haematoxylin and eosin (H&E) and all the islets were analysed. Results are expressed as mean ± standard error of the mean. *P < 0·05.